3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Basal Cell
5
Multiple Myeloma
3
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Lymphoma
2
Lung Neoplasms
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Platinum-Resistant Fallopian Tube Carcinoma
1
Neuroectodermal Tumors, Primitive
1
Neoplasms, Unknown Primary
1
Neoplasms, Basal Cell
1
Neoplasms
1
Meningioma
1
Melanoma
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Infratentorial Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Interventions
pembrolizumab
3
Nivolumab
3
Ifosfamide
3
Doxorubicin
3
AZD 6244
3
selinexor
2
pazopanib
2
fludarabine phosphate
2
Radiotherapy
2
Radiation
2
Magnetic Resonance Spectroscopy
2
thymoglobulin
1
tazemetostat
1
metarrestin
1
fludarabine
1
decitabine and cedazuridine drug combination
1
Thiotepa
1
Tacrolimus
1
Stem Cell Transplantation
1
Specimen Handling
1
Sirolimus
1
Proton Therapy
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Liquid Biopsy
1
Ipilimumab
1
Injections
1
Etoposide
1
Cyclosporins
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neurofibrosarcoma
×
HhAntag691
×
1 year
×
Clear all
No trials found.